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Abstract 1 
Background: Skin sympathetic nerve activity (SKNA) is useful in estimating sympathetic tone in 2 
humans  3 
Objective: To test the hypothesis that (1) increased SKNA is associated with the onset and 4 
termination of paroxysmal atrial tachycardia (AT) and AF and (2) The sinoatrial node (SAN) 5 
response to SKNA is reduced in patients with more frequent of AT or AF. 6 
Methods: SKNA and electrocardiogram were recorded in 11 patients (4 males and 7 females, 7 
average age 66±10 years), including 3 patients with AT (11±18 episodes/patient) and 8 patients 8 
with AF (24±26 episodes/patient).  9 
Results: The average SKNA (aSKNA, in µV) 10 s prior to AT onset were 1.07±0.10; 10 s after 10 
termination were 1.27±0.10, both were significantly (p=0.032, p<0.0001) higher than that during 11 
sinus rhythm (0.97±0.09). The aSKNA 10 s prior to AF onset were 1.34±0.07 and 10 s after 12 
termination were 1.31±0.07. Both were significantly (p<0.0001) higher than that during sinus 13 
rhythm (1.04±0.07). The aSKNA before onset (p<0.0001) and after termination (p= 0.0011) 14 
were both higher in AF than in AT. The sinus rate correlated (p<0.0001) with aSKNA in each 15 
patient (average r: 0.74, 95% confidence interval (CI): 0.65-0.84). The r in each patient 16 
negatively correlated with the number of AT and AF episodes (r= - 0.6493, 95% confidence 17 
interval:-0.8990 to -0.08073, p=0.0306). 18 
Conclusions: Increased SKNA was observed both at onset and termination of AT and AF. The 19 
patients with more frequent AT and AF episodes had less of a correlation between sinus rate 20 
and aSKNA, suggesting SAN remodeling by tachycardia. 21 
22 
Key words: arrhythmia; autonomic nervous system; cardiac electrophysiology; sick sinus 23 
syndrome; 24 
25 
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Introduction 1 
It is well documented that the autonomic nervous system plays an important role in 2 
arrhythmogenesis in both animal models and in humans.1, 2 Studies in ambulatory dogs 3 
documented an association between stellate ganglion nerve activity (SGNA) and the 4 
paroxysmal atrial tachyarrhythmias, including both atrial tachycardia (AT) and atrial fibrillation 5 
(AF).3-5 However, the invasive nature of SGNA monitoring limits its use in humans. The skin of 6 
the thorax and upper extremities is well innervated by sympathetic nerves. Tracer studies 7 
showed that the somata of these nerves originate in the cervical and stellate ganglia.6, 7 It is 8 
therefore possible that the sympathetic nerve activity recorded from the skin might be used to 9 
estimate SGNA. Consistent with the latter hypothesis, we found that subcutaneous nerve 10 
activity (SCNA) and surface skin sympathetic nerve activity (SKNA) in ambulatory dogs 11 
correlated well with SGNA.8-10 In addition, SCNA is more effective than heart rate variability in 12 
estimating the sympathetic tone.11 Encouraged by these results, we12 showed that it is possible 13 
to simultaneously record electrocardiogram (ECG) and SKNA using conventional ECG 14 
electrodes in humans. The same electrical signal can be filtered between 0.5 Hz and 150 Hz to 15 
display ECG, while high pass filtered at 200 Hz or higher to display SKNA. We named this 16 
recording method the neuECG because it is a method to simultaneously record neural 17 
discharges and ECG. The validity of neuECG recording was supported by the characteristics of 18 
nerve discharges recorded during cold water pressor test, Valsalva maneuvers and also by the 19 
correlation with heart rate and ventricular arrhythmias. In addition, lidocaine injection into the 20 
stellate ganglion abruptly reduced SKNA. The availability of neuECG made it feasible to test the 21 
hypothesis that sympathetic nerve activity is a direct trigger of paroxysmal AT and AF episodes 22 
in humans. Additionally, sick sinus syndrome is a commonly associated with atria 23 
tachyarrhythmias.13 Because reverse remodeling of sinoatrial node (SAN) function may occur 24 
after catheter ablation of AF,14 AT and AF may play an important role in the pathogenesis of 25 
sinus node dysfunction. Abnormal response of superior SAN to sympathetic stimulation is a 26 
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characteristic finding in patients with AF and symptomatic bradycardia.15 Because SKNA can be 1 
used to estimate sympathetic tone in humans,12 increased SKNA should result in a higher heart 2 
rate (HR). We hypothesize that the correlation between the average SKNA (aSKNA) and HR 3 
would be less in patients with higher frequency of AT and AF compared to those with lower 4 
frequency of AT and AF. The purpose of the present study was to test the hypotheses that 5 
increased SKNA is associated with the onset of AT and AF in humans, and that the frequency of 6 
AT and AF episodes is negatively associated with SAN response to sympathetic tone. 7 
 8 
Methods 9 
This research protocol was approved by the Institutional Review Board of the Indiana University 10 
School of Medicine. We reviewed the live telemetry recording of the inpatients and prospectively 11 
identified 11 patients (6 male, age 46 to 79) with paroxysmal atrial tachyarrhythmia for neuECG 12 
recording. Written and informed consent was obtained from each patient. 13 
 14 
Continuous neuECG Monitoring 15 
We used a modified portable ME6000 Biomonitor (Mega Electronics Ltd, Finland) for data 16 
acquisition.12 One channel was used to record ECG lead I on the chest with negative and 17 
positive electrodes in the right and left subclavian areas, respectively. A second channel was 18 
used to record SKNA from the right arm. The signals from neuECG were amplified and 19 
bandpass filtered (0.5 Hz-150 Hz) to show ECG. The same signals were bandpass filtered from 20 
500 Hz-1000 Hz to show SKNA. We analyzed recordings from all channels using custom-written 21 
software. 22 
 23 
Average SKNA and heart rate before onset and after termination of AT and AF 24 
AF was defined by a sudden onset of rapid irregular atrial activations with irregular ventricular 25 
responses. AT was defined by a sudden change from sinus rhythm to rapid (> 100 bpm) and 26 
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regular narrow QRS tachycardia. All onset and termination of the arrhythmia episodes were 1 
spontaneous. To determine the aSKNA and HR before and after termination of AT and AF, all 2 
AT and AF episodes lasting at least 10 s and separated by ≥ 10 s were identified. Shorter 3 
episodes were not included in the analyses. We integrated all digitized SKNA signals over that 4 
time window and divided the total voltage by the number of digitized samples in the same 5 
window to obtain the average voltage of aSKNA per sample. So that we can compare SKNA 6 
with traditional microneurography tracings,16 we also integrated SKNA over every 100 ms and 7 
plotted the results over time in the figures. The aSKNA and HR 10 s before onset, during the 8 
last 10 s of arrhythmia and within 10 s after termination of these AT and AF were analyzed. The 9 
frequency of AT or AF episodes were defined by the ratio between total episodes and the 10 
duration (hours) monitored. 11 
 12 
Statistical analysis 13 
Continuous variables were summarized by mean and standard deviation; categorical variables 14 
were summarized by frequency and percentage. Repeated measure ANOVA models were fitted 15 
first to perform an overall test to determine if continuous outcomes under different conditions 16 
have the same mean values. If the test was significant, paired T test was used to perform post-17 
hoc pairwise comparisons. Pearson correlation coefficient was used to measure linear 18 
correlation between continuous variables and Bonferroni correction was used to adjust 19 
significance level due to multiple tests. Linear mixed-effects models were used to analyze AT 20 
and AF episodes where subjects were treated as the random effect. All 95% confidence 21 
intervals are based on normal distributions of the measurements. Two-sided p values ≤0.05 22 
were considered statistically significant. 23 
 24 
Results 25 
Patient characteristic 26 
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The patient characteristics are shown in Table 1. We have a total of 11 patients, including 4 1 
males and 7 females with an average age of 66±10 years. Among them, 3 patients had AT and 2 
8 patients had AF. None of them had both types of arrhythmias. There were no complications 3 
associated with recording. 4 
 5 
Average SKNA increases prior to onset and after termination of AT 6 
We manually reviewed 34 episodes of AT in 3 patients (11±18 per patient). Among them, 7 
patient #10 had 32 episodes of AT while patients 1 and 4 had one episode each. The AT 8 
duration averaged 23.7±18.7 s. Figure 1 shows 2 episodes of AT from patient #10. Similar to 9 
that found in ambulatory dogs,3, 4 the onset of AT was preceded by increased SKNA (black 10 
arrows). In addition, there was a burst of SKNA and transient HR acceleration (by > 10 bpm in 11 
31 and by > 5 bpm in one episode) prior to AT termination (blue arrows). The same 12 
phenomenon was not found in the remaining 2 patients (Figure 2). Statistically, the aSKNA (µV) 13 
10 s prior to AT onset was 1.07±0.10, during the final 10 s of AT was 1.20±0.10, 10 s after 14 
termination was 1.27±0.10; all were significantly (p=0.032, p<0.0001, p<0.0001, respectively) 15 
higher than that during sinus rhythm (0.97±0.09) of the same patients.  16 
 17 
Average SKNA increases prior to onset and after termination of AF 18 
There was a total of 188 episodes of AF in 8 patients (24±26 per patient). The AF duration 19 
averaged 471.0±886.5 s. SKNA is significantly increased at the onset (Figure 3), during the 20 
final 10 s and within 10 s after termination of AF (Figure 4). In one episode, two beats of 21 
premature atrial contractions (PAC) preceded AF onset (3B, blue arrows). Statistically, the 22 
aSKNA (µV) 10 s prior to the onset was 1.34±0.07, during the final 10 s of AF was 1.29±0. 07, 23 
10 s after termination was 1.31±0.07; all were significantly (p<0.0001) higher than that of sinus 24 
rhythm (1.04±0.07).  25 
 26 
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AF is associated with higher average SKNA than AT 1 
We compared the aSKNA and HR during sinus rhythm and all AT and AF episodes 10 s before 2 
onset, during final 10 s of the episode, and 10 s after termination (Figure 5). The aSKNA 3 
associated with arrhythmias were mostly higher than that during sinus rhythm, but there were 4 
apparent overlaps of aSKNA associated with sinus rhythm and that with AT or AF. There was 5 
no threshold aSKNA above which AT or AF reliably followed.  The aSKNA before onset, during 6 
the final 10 s and after termination in AF were both significantly higher than that associated with 7 
AT episodes (p<0.0001, < 0.0001 and p= 0.0011, respectively), although large overlaps of 8 
aSKNA also existed between these two groups. 9 
 10 
Average SKNA and HR vs frequency of atrial tachyarrhythmia 11 
aSKNA and HR positively correlated with each other in all 11 patients (p<0.0001, average r: 12 
0.74, 95% CI: 0.65-0.84) (Figure 6A). Interestingly, the correlation coefficient of each patient 13 
negatively correlated with the number of AT and AF episodes per hour (r= - 0.6493, 95% 14 
confidence interval:-0.8990 to -0.08073, p=0.0306; Figure 6B). In other words, the higher the 15 
number of AT or AF episodes, the less responsive the SAN is to sympathetic activation. One 16 
outlier (black arrow in 6B) had > 100 short runs of AT but we only included 32 episodes (those 17 
lasted 10 s or longer) in this analyses. 18 
 19 
Discussion 20 
In this study we demonstrate several findings: (1) Distinct bursts in SKNA are associated with 21 
both onset and termination of paroxysmal atrial tachyarrhythmia. (2) aSKNA is increased before 22 
onset, during final 10 s and after termination of AF and AT compared to sinus rhythm. (3) 23 
aSKNA associated with AF are higher than that associated with AT. (4) aSKNA positively 24 
correlates with HR. However, the correlation becomes less strong as the frequency of AF and 25 
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AT increases, suggesting the frequency of AF and AT is a major factor responsible for SAN 1 
dysfunction. 2 
 3 
Autonomic mechanisms of AF onset 4 
The heart is heavily innervated by the autonomic nerves. This includes extrinsic and an intrinsic 5 
cardiac nervous system,17, 18 both of which consists of sympathetic and parasympathetic 6 
components and are important in arrhythmogenesis.1, 2 In ambulatory dogs, both extrinsic and 7 
intrinsic cardiac nerve activations frequently precede the onset of spontaneous AT and AF.3-5 8 
Ablation of the stellate ganglion or the ganglionated plexi (GP) reduced or eliminated these atrial 9 
arrhythmias.4, 19, 20 In humans, unilateral temporary stellate ganglion block might reduce AF 10 
inducibility and decrease AF duration.21 The neural mechanisms of AF is further substantiated 11 
by randomized controlled clinical trials that showed pulmonary vein isolation (PVI) plus GP 12 
ablation offered a 20-25% higher success rate compared to PVI alone in patients with AF.22, 23 13 
Another randomized trial showed that botulinum toxin injection in epicardial fat pads can prevent 14 
recurrences of AF after cardiac surgery.24 While epicardial fat pad ablation does not have long-15 
term effects in animal models,25 the same group of authors have later concluded that 16 
extensively ablating LA covering GP areas along with pulmonary vein antrum isolation 17 
enhanced the denervation of autonomic nerve system and seemed to improve procedural 18 
outcome in patients with AF.26 19 
On the other hand a recent study by Driessen et al27 concluded that GP ablation in 20 
addition to PVI and LA lines in patients with advanced AF (defined as persistent AF, enlarged 21 
left atria, or previously failed catheter ablation) did not reduce AF recurrence and had increased 22 
episodes of AT 12 months after surgery. We propose that there are several possibilities for this 23 
discrepancy. First, while important in inducing AF,5 GP activity may not be important in AF 24 
maintenance.19 Cryoablation of the stellate ganglia and cardiac branches of vagal nerve only 25 
prevented paroxysmal AF but not persistent AF in canine models.28  Therefore, the fact that 26 
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Driessen et al recruited patients with advanced (persistent) AF, many with prior failed ablations, 1 
may have significant implications on the results of the study. In contrast, Katritsis et al23 only 2 
recruited patients with paroxysmal AF and no prior ablation to the study, thus demonstrated the 3 
benefit of GP ablation. Secondly, Driessen et al may have concluded the study too early. In a 4 
study that compared PVI and GP ablation vs PVI and linear ablation in persistent AF, 5 
statistically significant difference was noted at 3-year follow up, but not at 1-year.29 The results 6 
of Driessen et al also shown a trend towards better outcomes for both paroxysmal and 7 
persistent AF at 1 year, but the differences were not statistically significant. It is possible that 8 
longer follow up is needed to demonstrate significant differences.   9 
The results of the present study provided further support of the neural mechanisms of 10 
AT and AF by directly measuring the sympathetic nerve activity in patients with spontaneous 11 
episodes of these arrhythmias. However, in some patients the aSKNA prior to onset of AT/AF 12 
overlapped significantly with the range of aSKNA during sinus rhythm. In those patients, the 13 
benefit of neuromodulation might be marginal. Further studies are needed to test the hypothesis 14 
that SKNA recording might be helpful in selecting patients for neuromodulation procedures. 15 
 16 
Bursts of SKNA prior to atrial tachycardia termination 17 
We demonstrated in one patient that all 32 AT episodes were terminated by a burst of SKNA 18 
and a brief acceleration of the heart rate. That sequence of events suggest that transient SKNA 19 
burst may be important in terminating AT, probably by overdrive suppression of the arrhythmia. 20 
In that patient, suppression of sympathetic tone by either drugs or non-pharmaceutical methods 21 
may have both antiarrhythmic and proarrhythmic effects. However, that phenomenon was not 22 
observed in the other 2 AT patients. The relationship between sympathetic tone and AT 23 
onset/termination may vary from patient to patient. Neuromodulation therapy may be beneficial 24 
in some patients, but is unlikely to be uniformly successfully in controlling AT and AF. Whether 25 
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or not neuECG is helpful in selecting patients for neuromodulation therapy deserves further 1 
study.  2 
 3 
Sinoatrial node dysfunction secondary to atrial tachyarrhythmia 4 
We found that the aSKNA and HR correlated with each other. However, the correlation 5 
coefficients reduced as the frequencies of AT and AF increased. This finding suggests that SAN 6 
was remodeled and became less responsive to sympathetic stimulation in patients with more 7 
frequent  AT and AF episodes. The association between SAN dysfunction and certain cardiac 8 
conditions, such as AF or heart failure, has been well described. In a study by Elvan et al,30 9 
pacing-induced chronic AF (2-6 weeks) induced SAN dysfunction, as evidenced by prolongation 10 
of SAN recovery time and decreases in intrinsic heart rates. Similar conclusions have been 11 
reported in humans.31-33 Moreover, it appears that the SAN dysfunction can be reversed after AF 12 
ablation.14 Acceleration of the calcium clock in the superior SAN plays an important role in sinus 13 
rate acceleration during beta-adrenergic stimulation.34 Abnormal responses of superior SAN to 14 
sympathetic stimulation is a characteristic finding in patients with AF and symptomatic 15 
bradycardia.15 Our results suggest that frequent tachyarrhythmia episodes may have remodeled 16 
the superior SAN and reduced the calcium clock response during sympathetic stimulation. 17 
Another implication is that the relationship between aSKNA and HR may be an indication of the 18 
AT and AF burden; a low r value suggests a high AF or AT burden.  19 
 20 
Limitations of the study 21 
Because the skin does not have parasympathetic nerves, SKNA can be used to specifically 22 
measure sympathetic but not parasympathetic tone. Our data could not be used to test the 23 
hypothesis that simultaneous sympathovagal discharges are often needed to induce AT and 24 
AF.4 An important new observation was that a burst of SKNA can accelerate AT rate, leading to 25 
AT termination. However, we only have one patient with that observation. It is not possible to 26 
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generalize these results to other AT patients. We do not have data in this study to determine if 1 
SKNA is causally related to AT/AF onset or termination. Due to the limitation of the equipment, 2 
we were limited to study hospitalized patients. These patients may not be representative of all 3 
patients with AT/AF. The study was not done during drug-free state, and the drugs can affect 4 
the results of the study. The same size is small, thus prevented effective subgroup analyses. 5 
 6 
Conclusions 7 
We conclude that increased SKNA is associated with both the onset and termination of AT and 8 
AF. The patients with more AT and AF episodes had less of a correlation between sinus rate 9 
and aSKNA, suggesting SAN remodeling by tachycardia episodes. These findings also suggest 10 
that SKAN may be a useful non-invasive tool in studying the neural mechanisms of cardiac 11 
arrhythmia. 12 
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Table 1. Patient characteristics 1 
# Age Gender Diagnoses 
 
CHA2DS2-VASc 
score 
Antiarrhythmic 
medications 
1 63 Female Hyperlipidemia 
Hypertension 
2 Metoprolol  
2 46 Female End-stage kidney disease 
Diabetes 
Hypertension 
Hyperlipidemia 
3 Metoprolol 
 
3 65 Female  Lung transplant  
Diastolic heart failure 
3 Amiodarone 
Metoprolol 
4 59 Male Hypertension  
Hyperlipidemia  
Lung transplant 
1 Amiodarone   
Metoprolol   
 
5 74 Female Diastolic heart failure  
Metastatic renal cell carcinoma  
3 Metoprolol 
 
6 79 Female  Coronary artery disease 
Coronary artery bypass grafting 
Hyperlipidemia 
Hypertension 
4 Amiodarone  
Metoprolol  
7 58 Male Aortic dilation  
Aortic valve replacement 
1 Amiodarone 
8 74 Male Coronary artery disease 
Severe aortic stenosis  
3 Metoprolol 
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Diabetes  
Hypertension 
9 68 Male  Coronary artery disease 
Myocardial infarction  
Abdominal aortic aneurysm  
Hypertension  
Hyperlipidemia  
Factor V Leiden deficiency.  
4 Amiodarone  
Metoprolol  
Verapamil  
10 66 Female Hypertension  
Diabetes  
End stage kidney disease 
4 Metoprolol  
11 78 Female Coronary Artery Disease 
Coronary Artery Bypass 
Heart Failure 
Mitral valve replacement 
Tricuspid valve replacement 
Chronic Kidney Disease 
Chronic Anemia 
6 Carvedilol 
 
 1 
 2 
 3 
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Figure 1. SKNA characteristics before onset and after termination of AT in patient #10, who has 2 
32 episodes of AT fulfilling the inclusion criteria. Signals were high bandpass filtered from 500 3 
Hz-1000 Hz to reveal SKNA and from 0.5 Hz-150 Hz to reveal ECG. iSKNA was obtained by 4 
integrating the voltage of digitized data over 100 ms windows. (A) Multiple episodes of SKNA 5 
bursts (black arrows) were present within 30 s (double headed arrows) prior to AT onset. Heart 6 
rate acceleration (green arrows) associated with SKNA burst (blue arrows) was observed prior 7 
to AT termination (red dotted line). This phenomenon was present in all 32 AT termination 8 
episodes analyzed for this patient. SKNA continues to be elevated during the 30 s after 9 
termination. SKNA was also increased during premature atrial contraction (arrowhead). (B) 10 
Similar findings in a separate AT episode, consistent with (A).  11 
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Figure 2. NeuECG recording of an AT episode from patient #1. SKNA is slightly elevated prior 2 
to (blue arrows) and at the onset of AT (downward black arrows). A short burst of SKNA (blue 3 
arrows) was observed prior to termination, but was not associated with HR acceleration. There 4 
was no SKNA elevation after termination. Each double headed arrow indicates 30 s.  5 
 6 
 7 
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Figure 3. NeuECG recording of AF onset in patient #7. (A) SKNA is significantly increased prior 2 
to AF onset (black arrows). Double arrows indicate 10 s. (B) Similar findings in a separate AF 3 
episode of the same patient. SKNA is significantly increased prior to AF onset (black arrows). 4 
Two beats of premature atrial contractions preceded the onset (blue arrows), also associated 5 
with higher SKNA.  6 
 7 
 8 
 9 
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Figure 4. NeuECG recording of AF termination. (A) Significant increase in SKNA was observed 2 
in patient #7 before and after spontaneous termination of AF (black arrows). The double arrows 3 
indicate 10 s. A premature atrial contraction was recorded after termination of AF (blue arrow). 4 
(B) Similar to (A), increased SKNA was observed before and after termination of AF in patient 5 
#8. 6 
 7 
 8 
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Figure 5. Characteristics of aSKNA and HR before, during last 10 s, and after AF or AT 3 
episodes. aSKNA before onset (red), during final 10 s (green) and after termination (blue) of 4 
both AT and PF episodes is greater than that of sinus rhythm (black) (p<0.0001). Overall, 5 
aSKNA before onset, during final 10 s and after termination of AF were both higher than that of 6 
AT. However, there is significant overlap within and variation among different individuals. For 7 
example, patient #10 had AT, but the aSKNA in this particular patient is higher than the other 8 
AT patients (#1, #4), as well as several AF patients (#3, #8, #11).  9 
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Figure 6. Correlation between aSKNA and HR and its relationship to frequency of AT or AF. (A) 3 
aSKNA and HR positively correlated with each other in all 11 patients. (B) Correlation coefficient 4 
of each patient is inversely correlated to the frequency of AT or AF episodes in the same 5 
patient. The more frequent a patient has AT or AF episodes, the less sensitive their HR is to 6 
sympathetic activation as detected by neuECG via skin. The outlier (black arrow) is from patient 7 
#10, who had > 100 short runs of AT but only 32 was ≥ 10 s and were included in the analyses. 8 
If we included all short burst of AT in the analyses, then his r value may not be lower than 9 
expected. 10 
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